High Body Mass Index Shortens Retention of Tumor Necrosis Factor-α Blocker Treatment in Rheumatoid Arthritis

被引：0
|
作者：
Elkayam, Ori [1 ]
Lidar, Merav [2 ]
Reitblat, Tatiana [3 ]
Zisman, Devy [4 ]
Balbir-Gurman, Alexandra [5 ]
Kakakian, Odelia [1 ]
Meshiach, Tanya [5 ]
Almog, Ronit [6 ]
Elalouf, Ofir [1 ]
机构：
[1] Tel Aviv Med Ctr & Sch Med, Tel Aviv, Israel
[2] Sheba Med Ctr, Rheumatol Unit, Ramat Gan, Israel
[3] Barzilai Govt Hosp, Ashqelon, Israel
[4] Carmel Hosp, Haifa, Israel
[5] Rambam Med Ctr, Haifa, Israel
[6] Rambam Hlth Care Campus, Epidemiol & Biostat Unit 7, Haifa, Israel
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2359
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Polymorphisms in the 5′-flanking region of tumor necrosis factor-α gene in patients with rheumatoid arthritis
    Seki, N
    Kamizono, S
    Yamada, A
    Higuchi, T
    Matsumoto, H
    Niiya, F
    Kimura, A
    Tsuchiya, K
    Suzuki, R
    Date, Y
    Tomita, T
    Itoh, K
    Ochi, T
    [J]. TISSUE ANTIGENS, 1999, 54 (02): : 194 - 197
  • [42] Risk of Heart Failure in Rheumatoid Arthritis Patients Treated with Tumor Necrosis Factor-α Inhibitors
    Chen, Hung-Kai
    Shao, Shih-Chieh
    Weng, Meng-Yu
    Lin, Swu-Jane
    Hung, Ming-Jui
    Chan, Yuk-Ying
    Lai, Edward Chia-Cheng
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (06) : 1595 - 1603
  • [43] Tumor necrosis factor-α antagonist use and heart failure in elderly patients with rheumatoid arthritis
    Setoguchi, Soko
    Schneeweiss, Sebastian
    Avorn, Jerry
    Katz, Jeffrey N.
    Weinblatt, Michael E.
    Levin, Raisa
    Solomon, Daniel H.
    [J]. AMERICAN HEART JOURNAL, 2008, 156 (02) : 336 - 341
  • [44] -308 A/G polymorphism in the tumor necrosis factor-α gene influences outcome of etanercept treatment in rheumatoid arthritis.
    Guis, Sandrine, Sr.
    Balandraud, Nathalie
    Bouvenot, Julien
    Auger, Isabelle
    Mugnier, Benedicte
    Toussirot, Eric
    Wendling, Daniel
    Mattei, Jean Pierre
    Tomachot, Benoit
    Legeron, Pierre
    Landt, Olfert
    Roudier, Jean
    Roudier, Chantal
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S231 - S231
  • [45] ULTRASONOGRAPHIC ASSESSMENT OF JOINT INFLAMMATION IN RHEUMATOID ARTHRITIS: PREDICTIVE VALUE IN RESPONSE TO TUMOR NECROSIS FACTOR-α INHIBITOR TREATMENT
    Inanc, N.
    Ozen, G.
    Direskeneli, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 468 - 468
  • [46] Anti-tumor necrosis factor-α monoclonal antibody therapy for rheumatoid arthritis.
    Mugnier, B
    Bouvenot, G
    [J]. REVUE DE MEDECINE INTERNE, 2000, 21 (10): : 854 - 862
  • [47] The Effect of Tumor Necrosis Factor-α Antagonists on Arterial Stiffness in Rheumatoid Arthritis: A Literature Review
    Dulai, Rajdip
    Perry, Mark
    Twycross-Lewis, Richard
    Morrissey, Dylan
    Atzeni, Fabiola
    Greenwald, Stephen
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2012, 42 (01) : 1 - 8
  • [48] Anti-tumor necrosis factor-α agents for rheumatoid arthritis:: Assessing longterm safety
    Hyrich, KL
    Silman, AJ
    [J]. JOURNAL OF RHEUMATOLOGY, 2006, 33 (05) : 831 - 833
  • [49] Tumor Necrosis Factor- Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis
    Desai, Rishi J.
    Solomon, Daniel H.
    Schneeweiss, Sebastian
    Danaei, Goodarz
    Liao, Katherine P.
    Kim, Seoyoung C.
    [J]. EPIDEMIOLOGY, 2016, 27 (03) : 414 - 422
  • [50] Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: Effects of tumor necrosis factor-α blockade
    Ingegnoli, Francesca
    Fantini, Flavio
    Favalli, Ennio Giulio
    Soldi, Amedeo
    Griffini, Samantha
    Galbiati, Valentina
    Meroni, Pier Luigi
    Cugno, Massimo
    [J]. JOURNAL OF AUTOIMMUNITY, 2008, 31 (02) : 175 - 179
12345